Medical & Hemp Program

MRTA Article 5, Sections 90–111 control who must be licensed, how hemp products are made and sold, what testing and labeling are required, and how the State enforces compliance. Hemp is regulated separately from adult-use cannabis. Holding an adult-use license does not authorize hemp activity.

MRTA Article 5, Sections 90–99 regulate cannabinoid hemp separately from adult-use cannabis. If you manufacture, process, package, or sell hemp-derived products intended for human consumption, you must hold a hemp license under Article 5, even if you already hold an adult-use cannabis license under Article 4.

New York’s medical cannabis program operates separately from the adult-use system. Only Registered Organizations (ROs) may cultivate, manufacture, and dispense medical cannabis, and only certified patients and caregivers may purchase it. If you are not operating as, or co-located with, an RO, these rules generally do not apply to your retail operations. Understanding the distinction prevents compliance errors and customer confusion.

This page organizes official rules, bulletins, FAQs, and memos so operators can work with confidence and avoid compliance risks.

ROs form the core of New York’s medical cannabis market and may participate in the adult-use system through a regulated dual-license and co-location framework. This page explains what ROs are allowed to do, how they operate, and how they must comply with both medical and adult-use requirements.

Duis aute irure dolor in reprehenderit commo voluptate velit esse cillum dolore eu fugiat.

Ut enim ad minim veniam quis nostrud exercita ullamco laboris nisi ut aliquip ex ea commodo.

Duis aute irure dolor in reprehenderit commo voluptate velit esse cillum dolore eu fugiat.

Excepteur sint occaecat cupidatat nondolore proident sunt in culpa qui officia deserunt.